J. Heaton

发表

Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma.

R. Kuick, T. Giordano, Dafydd G. Thomas, 2009, The Journal of clinical endocrinology and metabolism.

Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides.

T. Gelehrter, S. Kathju, J. H. Heaton, 1992, Molecular endocrinology.

Cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor messenger RNAs in rat hepatoma cells.

T. Gelehrter, J. Heaton, 1990, Molecular endocrinology.

Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells.

T. Gelehrter, J. H. Heaton, J. Heaton, 1989, Molecular endocrinology.

Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes.

T. Gelehrter, S. Morris, J. H. Heaton, 1989, Molecular endocrinology.

Derepression of amino acid transport by amino acid starvation in rat hepatoma cells.

T. Gelehrter, J. Heaton, 1977, The Journal of biological chemistry.

Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase‐type PA, PA inhibitor‐1 mRNA, and protein in rat osteoblast‐like cells

T. Gelehrter, S. Fukumoto, R. Zeheb, 1991, Journal of cellular physiology.

Insulin resistance in H-35 rat hepatoma cells is mediated by post-receptor mechanisms

N. Krett, T. Gelehrter, J. H. Heaton, 1983, Molecular and Cellular Endocrinology.

Regulation of insulin responsiveness in rat hepatoma cells.

T. Gelehrter, J. H. Heaton, J. Heaton, 1980, Biochemical and biophysical research communications.

In search of adrenocortical stem and progenitor cells.

J. Scheys, G. Hammer, T. Else, 2009, Endocrine reviews.

SUMOylation Inhibits SF-1 Activity by Reducing CDK7-Mediated Serine 203 Phosphorylation

J. Iñiguez-Lluhí, G. Hammer, Holly N. Brevig, 2008, Molecular and Cellular Biology.

Role of steroid receptor coactivators in glucocorticoid and transforming growth factor beta regulation of plasminogen activator inhibitor gene expression.

T. Gelehrter, J. H. Heaton, Gangyong Li, 2006, Molecular endocrinology.

Dicer deficiency reveals microRNAs predicted to control gene expression in the developing adrenal cortex.

G. Hammer, Katherine Gurdziel, D. Simon, 2013, Molecular endocrinology.

Identification and cDNA Cloning of a Novel RNA-binding Protein That Interacts with the Cyclic Nucleotide-responsive Sequence in the Type-1 Plasminogen Activator Inhibitor mRNA*

M. Dlakić, T. Gelehrter, Wendy M. Dlakic, 2001, The Journal of Biological Chemistry.

Synergistic induction of tissue-type plasminogen activator gene expression by glucocorticoids and cyclic nucleotides in rat HTC hepatoma cells.

T. Gelehrter, S. Kathju, C. Bruzdzinski, 1994, Endocrinology.

Cyclic Nucleotide Regulation of PAI-1 mRNA Stability

T. Gelehrter, J. H. Heaton, M. Tillmann-Bogush, 1999, The Journal of Biological Chemistry.

Cyclic Nucleotide Regulation of Type-1 Plasminogen Activator-Inhibitor mRNA Stability in Rat Hepatoma Cells

T. Gelehrter, J. H. Heaton, M. Tillmann-Bogush, 1998, The Journal of Biological Chemistry.

Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.

R. Kuick, T. Giordano, Dafydd G. Thomas, 2012, The American journal of pathology.

Evidence of adrenal failure in aging Dax1-deficient mice.

J. Scheys, G. Hammer, Joshua O. Scheys, 2011, Endocrinology.

Posttranscriptional regulation of PAI-1 gene expression

T. Gelehrter, Wendy M. Dlakic, J. Heaton, 2003, Thrombosis and Haemostasis.

Post-Transcriptional Control of Type-1 Plasminogen Activator Inhibitor mRNA

T. Gelehrter, J. Heaton, 2002 .

Thrombin induction of plasminogen activator inhibitor mRNA in human umbilical vein endothelial cells in culture.

T. Gelehrter, M. Dame, J. Heaton, 1992, The Journal of laboratory and clinical medicine.

Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability

T. Gelehrter, J. Innis, Thomas M. Williams, 2005, Nucleic acids research.

Adrenocortical Stem and Progenitor Cells: Implications for Cancer

G. Hammer, J. Heaton, 2009 .

Insulin selectively slows the degradation rate of tyrosine aminotransferase.

T. Gelehrter, J. H. Heaton, C. Spencer, 1978, The Journal of biological chemistry.

Induction of tyrosine aminotransferase and amino acid transport in rat hepatoma cells by insulin and the insulin-like growth factor, multiplication-stimulating activity. Mediation by insulin and multiplication-stimulating activity receptors.

M. Rechler, S. Nissley, E. Schilling, 1980, Biochimica et biophysica acta.

Insulin regulation of insulin-like growth factor action in rat hepatoma cells.

M. Rechler, N. Krett, T. Gelehrter, 1984, The Journal of biological chemistry.

Desensitization of hepatoma cells to insulin action. Evidence for a post-receptor mechanism.

T. Gelehrter, J. H. Heaton, J. Heaton, 1981, The Journal of biological chemistry.

Mediation of insulin-like growth factor actions by the insulin receptor in H-35 rat hepatoma cells.

N. Krett, T. Gelehrter, J. H. Heaton, 1987, Endocrinology.

Regulation of insulin and insulin-like growth factor (IGF) responsiveness by IGFs in rat hepatoma cells.

N. Krett, T. Gelehrter, J. H. Heaton, 1986, Endocrinology.

In search of adrenocortical stem and progenitor cells.

G. Hammer, T. Else, D. Simon, 2009, Endocrine reviews.